bw a868c has been researched along with ah 23848 in 1 studies
| Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (ah 23848) | Trials (ah 23848) | Recent Studies (post-2010) (ah 23848) |
|---|---|---|---|---|---|
| 47 | 0 | 11 | 89 | 3 | 12 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leff, P; Lydford, SJ; McKechnie, KC | 1 |
1 other study(ies) available for bw a868c and ah 23848
| Article | Year |
|---|---|
Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
Topics: Animals; Anti-Arrhythmia Agents; Biphenyl Compounds; Dinoprostone; Dose-Response Relationship, Drug; Hydantoins; Male; Potassium Chloride; Prostaglandin D2; Rabbits; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Saphenous Vein | 1996 |